 |
Xoma
Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to ta
http://www.xoma.com/
Xoma.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
ZymoGenetics, Inc.
Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. Includes product pipeline, news on clinical trials and profile of company in Seattle, Washington.
http://www.zymogenetics.com/
Zymogenetics.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
Hemobiotech Inc.
Developer of blood substitute, aiming to address intrinsic hemoglobin toxicity. Introduction to company and their work, with form to contact Dallas, Texas.
http://www.hemobiotech.com/
Hemobiotech.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
Gemac
Researching diagnostics and drug candidates for the treatment of amyotrophic lateral and multiple sclerosis, as well as autoimmune diseases, including anti-idiotypic antibodies. Includes overview of corporation in Cenon, France.
http://www.gemacbio.com/
Gemacbio.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
Xencor, Inc.
Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDA™ Technolog
http://www.xencor.com/
Xencor.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
MannKind Corp.
Developing a pulmonary insulin delivery system, and immunotherapy of cancer, by identifying tumor-related antigens, DNA and peptide-based drugs evoking cell-mediated responses. Located in Valencia, California.
http://www.mannkindcorp.com/
Mannkindcorp.com ~
Site Info
Whois
Trace Route
RBL Check
|
|
|
|
